An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study - Ahmed, F; Gaul, C; García-Moncó, J C; Sommer, K; Martelletti, P; REPOSE Principal Investigators (J Headache Pain, 2019)